Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are we aggressive enough in lowering cholesterol?

D D Waters1

  • 1Cardiology Division, Department of Medicine, San Francisco General Hospital, San Francisco, California 94110, USA. dwaters@medsfgh.ucsf.edu

The American Journal of Cardiology
|August 25, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Action of nifedipine in ischemic heart disease.

Canadian family physician Medecin de famille canadien·2011
Same author

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.

Neurology·2010
Same author

Do statins confer early benefit after acute coronary syndromes? The results from FLORIDA.

European heart journal·2002
Same author

Short- and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction.

The American journal of cardiology·2002
Same author

Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability.

The American journal of cardiology·2002
Same author

Low-density-lipoprotein cholesterol goals for patients with coronary disease: treating between the lines.

Circulation·2001
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Statin therapy significantly reduces mortality and major coronary events by lowering low-density lipoprotein cholesterol (LDL-C). Lowering cholesterol levels, regardless of baseline, is crucial for cardiovascular risk reduction in broad patient populations.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Epidemiological studies consistently show a correlation between lower cholesterol levels and reduced cardiovascular risk.
  • Statin medications are widely used to manage cholesterol levels.

Purpose of the Study:

  • To evaluate the efficacy of statin therapy in reducing mortality and major coronary events.
  • To assess the impact of lowering low-density lipoprotein cholesterol (LDL-C) on cardiovascular outcomes.

Main Methods:

  • Analysis of data from five major randomized, placebo-controlled statin trials.
  • Inclusion of diverse patient groups, including those with and without pre-existing coronary artery disease and varying LDL-C levels.

Main Results:

Related Experiment Videos

  • Statin therapy significantly reduced total mortality and major coronary events across all patient groups.
  • Consistent evidence supports a direct relationship between lower LDL-C levels and decreased cardiovascular risk.

Conclusions:

  • Aggressively targeting LDL-C reduction with statins is strongly supported for both primary and secondary prevention of coronary disease.
  • The findings reinforce the importance of statin therapy in managing cardiovascular health.